Aller au contenu

Where we come from

Our history

The bond between humans and animals: a family heritage

Born in Auvergne, looking to the future

Three generations of entrepreneurs

From the pharmacy founded by René Moulin to today’s international group, three generations have followed one another with the same conviction: to advance animal health while remaining free to innovate, invest and build the future.

1947

From the first pharmacy to a group present in 35 countries, our story has been written for almost 80 years around a single ambition: supporting those who care for animals.

1st generation

Pioneers of animal health

The story of DÔMES PHARMA begins after the Second World War with René MOULIN, a pharmacist in Clermont-Ferrand. Passionate about animals and nature, he anticipated the growing need for veterinary products for companion animals at a time when attention focused more on the care of farm animals. At the back of his pharmacy, he developed a range, Produits Vétérinaires Moulin, which soon gained a local reputation.

In 1963, his wife Simone MOULIN persuaded him to move into industrial production. They acquired the Biocanina range and built the Vétocentre plant to manufacture it. Promotion and distribution to pharmacists by La Cooper extended the range’s reputation nationwide. Simone MOULIN ran Vétocentre for 32 years. In the 1970s she was joined by her son Jean MOULIN, keen to diversify the customer base by offering the range to vets.

2nd generation

A focus on regulation and the creation of an industrial group

Jean MOULIN took up the challenge of entering this new market and bought IEA, a small Parisian herbal medicine laboratory, which he moved to Auvergne. It was at this time that he asked his friend Chantal LUGNIER, also a pharmacist, to join him in the venture.

In 1975, a public health law was passed to regulate the manufacture of veterinary medicines. This created a very bold opportunity for Jean MOULIN and Chantal LUGNIER to buy Laboratoire TVM, the veterinary division of the Chauvin-Blache laboratories, specialists in human ophthalmology. To secure their laboratory’s future, the directors set themselves two main goals: meeting regulatory requirements and growing the sales force. The 1990s and 2000s were notably marked by the ambitious construction of a medicine production plant, EUROPHARTECH (1992), and the launch of flagship medicines for the TVM laboratory such as Vitamin K1 and Lopéral. It was also at the end of the 2000s that the Group began its export distribution activity in a few European countries.

3rd generation

International ambition

Drawing on experience built within the Group and abroad, Anne MOULIN took over the management of Dômes Pharma in 2008 before becoming Chair of the EXCOM in 2016. Convinced that Dômes Pharma’s growth depends on a stronger presence close to vets, she set the Group on an ambitious path of international expansion. Under her leadership, Dômes Pharma opened its first commercial subsidiary in the United Kingdom in 2016, marking the start of a new phase of growth. This strategy continued with the Group’s development in Germany, Spain, the United States and, more recently, Canada, steadily strengthening its presence in the main animal health markets.

This expansion goes hand in hand with the development of new areas of expertise, major industrial investments and a firm determination to remain an independent player, able to support veterinary professionals as closely as possible to their needs, wherever care is delivered.

In 2020, Anne Moulin embedded this ambition in a sustainable development strategy combining performance, responsibility and long-term growth. Today, this vision continues to guide the Group’s development while remaining true to its mission: supporting those who care for animals, wherever care is delivered.